Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
60.55
+1.47 (2.49%)
Nov 13, 2026, 3:04 PM CST

SHE:300832 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,300997.44919.531,048483.43617.58
Short-Term Investments
-1,12675275.79110.09-
Trading Asset Securities
1,4391,2671,7232,0802,8142,806
Cash & Short-Term Investments
2,7393,3902,7183,4043,4073,424
Cash Growth
21.23%24.74%-20.16%-0.09%-0.49%1.46%
Accounts Receivable
924.411,001957.49631.78479.97276.1
Other Receivables
9.76239.52147.9880.6642.8312.69
Receivables
934.171,2401,105712.44522.79288.79
Inventory
1,1111,0401,198916.79839.33645.38
Prepaid Expenses
15.6911.6723.727.4432.29104.75
Other Current Assets
1,55611.6110.7523.0920.834.16
Total Current Assets
6,3565,6945,0565,0644,8224,497
Property, Plant & Equipment
1,8361,7631,6941,4421,3251,134
Long-Term Investments
1,0811,5311,974924.95357.62136.9
Other Intangible Assets
227.96237.39245.06169.46172.4894.56
Long-Term Accounts Receivable
407.14392.46310.8189.1793.8528.1
Long-Term Deferred Tax Assets
106.1187.3563.9837.9422.912.14
Long-Term Deferred Charges
108.77125.73150.83156.6969.0874.97
Other Long-Term Assets
141.15109.79124.8238.22150.77157.39
Total Assets
10,2659,9419,6198,2227,0156,136

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
198.09152.11456.62126.99176.68171.35
Accrued Expenses
145.92222.03200.59187.77149.03124.27
Current Portion of Leases
1.551.821.341.691.321.35
Current Income Taxes Payable
183.7198.3120.14120.3576.1959.92
Current Unearned Revenue
79.7187.7380.1391.48108.9477.08
Other Current Liabilities
92.471.8949.9163.271.7873.96
Total Current Liabilities
701.38633.89908.74591.48583.94507.94
Long-Term Leases
1.071.862.763.490.890.88
Long-Term Unearned Revenue
44.9646.4347.2633.065.816.58
Long-Term Deferred Tax Liabilities
110.54106.9778.5150.0624.418.11
Other Long-Term Liabilities
7.256.765.58---
Total Liabilities
865.21795.911,043678.09615.06523.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
785.72785.72785.72785.72786.13786.66
Additional Paid-In Capital
1,3381,3321,3321,3321,3481,450
Retained Earnings
7,4667,0166,4175,3744,2673,411
Treasury Stock
-200.04----16.29-37.51
Comprehensive Income & Other
10.0911.1441.7252.713.991.64
Shareholders' Equity
9,4009,1458,5777,5446,3995,612
Total Liabilities & Equity
10,2659,9419,6198,2227,0156,136

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2.633.684.15.182.222.24
Net Cash (Debt)
2,7373,3872,7143,3993,4053,422
Net Cash Growth
21.32%24.79%-20.16%-0.17%-0.49%1.40%
Net Cash Per Share
3.484.313.454.334.334.35
Filing Date Shares Outstanding
782.36785.72785.72785.72786.13786.66
Total Common Shares Outstanding
782.36785.72785.72785.72786.13786.66
Working Capital
5,6555,0604,1474,4734,2383,989
Book Value Per Share
12.0111.6410.929.608.147.13
Tangible Book Value
9,1728,9078,3327,3756,2275,517
Tangible Book Value Per Share
11.7211.3410.609.397.927.01
Buildings
-1,0611,0611,061541.55516.8
Machinery
-887.94811.8659.08512.48427.32
Construction In Progress
-549.45414.56169.32605.7442.99